12.14.10
Kathleen P. Bloch has been appointed chief financial officer of Laureate Pharma. Ms. Bloch is responsible for finance, accounting and IT activities in addition to serving as a member of the company's management committee. Her primary objective is to increase capital and provide a platform for the continued growth of the company. Her plans include the development of interactive financial reporting systems, including a project-facing system and a materials management system aimed at enhancing client relationships.
"Kathy brings more than 20 years executive financial experience to Laureate and she has managed growth and driven performance in rapidly-expanding manufacturing environments," said Michael A. Griffith, chief executive officer of Laureate. "She possesses the knowledge and expertise required to lead Laureate Pharma as we invest and grow."
Ms. Bloch joins the company from PC Group, Inc., where she served as chief operating officer and chief financial officer since 2007. Prior to this, Ms. Bloch managed day-to-day operations for The Silverman Group, a real estate and investment company.
"Kathy brings more than 20 years executive financial experience to Laureate and she has managed growth and driven performance in rapidly-expanding manufacturing environments," said Michael A. Griffith, chief executive officer of Laureate. "She possesses the knowledge and expertise required to lead Laureate Pharma as we invest and grow."
Ms. Bloch joins the company from PC Group, Inc., where she served as chief operating officer and chief financial officer since 2007. Prior to this, Ms. Bloch managed day-to-day operations for The Silverman Group, a real estate and investment company.